UY34719A - Proceso para la producción de inhibidores de crr - Google Patents

Proceso para la producción de inhibidores de crr

Info

Publication number
UY34719A
UY34719A UY0001034719A UY34719A UY34719A UY 34719 A UY34719 A UY 34719A UY 0001034719 A UY0001034719 A UY 0001034719A UY 34719 A UY34719 A UY 34719A UY 34719 A UY34719 A UY 34719A
Authority
UY
Uruguay
Prior art keywords
crr
inhibitors
production
pág
escanear
Prior art date
Application number
UY0001034719A
Other languages
English (en)
Spanish (es)
Inventor
Duran Adil
Schmid Rolf
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY34719A publication Critical patent/UY34719A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
UY0001034719A 2012-04-02 2013-04-02 Proceso para la producción de inhibidores de crr UY34719A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12162852 2012-04-02

Publications (1)

Publication Number Publication Date
UY34719A true UY34719A (es) 2013-10-31

Family

ID=47998462

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034719A UY34719A (es) 2012-04-02 2013-04-02 Proceso para la producción de inhibidores de crr

Country Status (9)

Country Link
US (1) US8680280B2 (enExample)
EP (1) EP2834229B1 (enExample)
JP (1) JP6255550B2 (enExample)
AR (1) AR090566A1 (enExample)
DK (1) DK2834229T3 (enExample)
ES (1) ES2641862T3 (enExample)
TW (1) TW201400474A (enExample)
UY (1) UY34719A (enExample)
WO (1) WO2013149926A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278302B2 (en) 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
UA109290C2 (uk) 2010-10-07 2015-08-10 Спільні кристали і солі інгібіторів ccr3
AR090566A1 (es) 2012-04-02 2014-11-19 Boehringer Ingelheim Int Proceso para la produccion de inhibidores de crr
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
NZ757769A (en) 2017-04-05 2025-10-31 Alkahest Inc Methods and compositions for treating retina-associated disease using ccr3-inhibitors
WO2018187503A1 (en) 2017-04-05 2018-10-11 Alkahest, Inc. Methods and compositions for treating aging-associated impairments using ccr3-inhibitors
AU2019271122A1 (en) 2018-05-15 2020-11-12 Alkahest, Inc. Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase
US11957671B2 (en) 2021-11-01 2024-04-16 Alkahest, Inc. Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7907121L (sv) 1979-08-27 1981-02-28 Astra Laekemedel Ab Ftalimidinderivat
JP2807577B2 (ja) 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
JPH08134041A (ja) * 1994-11-10 1996-05-28 Fuji Photo Film Co Ltd ピラゾールアミド類の製造方法
EP1047675A1 (en) 1998-01-21 2000-11-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6140349A (en) 1998-02-02 2000-10-31 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
JP2002501898A (ja) 1998-02-02 2002-01-22 メルク エンド カムパニー インコーポレーテッド ケモカイン受容体活性の環状アミン調節剤
ES2324224T3 (es) 2004-02-05 2009-08-03 Schering Corporation Derivados de piperidina que se pueden utilizar como antagonistas ccr3.
JP2006137718A (ja) 2004-11-12 2006-06-01 Astellas Pharma Inc インドール若しくはインダゾール誘導体
WO2006083390A2 (en) 2004-12-07 2006-08-10 Children's Hospital Medical Center Eotaxin-3 in eosinophilic esophagitis
DOP2006000051A (es) * 2005-02-24 2006-08-31 Lilly Co Eli Inhibidores de vegf-r2 y métodos
EP2059515A2 (en) 2006-04-12 2009-05-20 Pfizer Limited Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
GB0701992D0 (en) 2007-02-02 2007-03-14 7Tm Pharma As Grehlin Receptor Modulators
US8008092B2 (en) 2007-10-09 2011-08-30 University Of Kentucky Research Foundation CCR3 inhibition for ocular angiogenesis and macular degeneration
TW201000446A (en) 2008-05-30 2010-01-01 Astrazeneca Ab New compounds useful in pain therapy
US8278302B2 (en) 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
UA109290C2 (uk) 2010-10-07 2015-08-10 Спільні кристали і солі інгібіторів ccr3
AR090566A1 (es) 2012-04-02 2014-11-19 Boehringer Ingelheim Int Proceso para la produccion de inhibidores de crr
US20130261153A1 (en) 2012-04-03 2013-10-03 Boehringer Ingelheim International Gmbh Use of ccr3-inhibitors
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists

Also Published As

Publication number Publication date
US20130261307A1 (en) 2013-10-03
ES2641862T3 (es) 2017-11-14
DK2834229T3 (da) 2017-11-20
EP2834229B1 (en) 2017-08-09
TW201400474A (zh) 2014-01-01
AR090566A1 (es) 2014-11-19
EP2834229A1 (en) 2015-02-11
WO2013149926A1 (en) 2013-10-10
US8680280B2 (en) 2014-03-25
JP6255550B2 (ja) 2018-01-10
JP2015516959A (ja) 2015-06-18

Similar Documents

Publication Publication Date Title
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34472A (es) Derivados modificados de 4-fenil-piridina
UY34550A (es) Bencilpirazoles sustituidos
UY34145A (es) Compuestos inhibidores de metaloenzimas
UY34146A (es) Compuestos inhibidores de metaloenzimas
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
UY33925A (es) Inhibidores tricíclicos de quinasas
UY34591A (es) Compuestos de imidazopirrolidinona
UY34559A (es) Inhibidores de bromodominios
MX378288B (es) Inhibidores de pirimidina del fgfr4.
UY34374A (es) Benzilindazoles sustituidos
UY34156A (es) Compuestos inhibidores de metaloenzimas
UY34648A (es) Amidas como inhibidores de pim
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
UY34660A (es) Inhibidores de benzodioxano de la producción de leucotrieno
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
UY34393A (es) Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor xia
UY34108A (es) ?proceso para la fabricación de sustratos revestidos?.
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
UY34817A (es) Tienopirimidinas
UY34767A (es) Inhibidores cíclicos del enlace éter de dgat1
UY34523A (es) Derivados de betulina
UY34034A (es) Triazolopiridinas
UY34661A (es) Inhibidores de benzodioxano de la producción de leucotrieno para terapia de combinación
UY34719A (es) Proceso para la producción de inhibidores de crr